>
Course Unit Title | Course Unit Code | Type of Course Unit | Level of Course Unit | Year of Study | Semester | ECTS Credits |
---|---|---|---|---|---|---|
Observation Of Drug Blood Level | FRM608 | Elective | Doctorate degree | 1 | Spring | 6 |
Prof. Dr. Bekir Faruk ERDEN
Prof. Dr. Oğuz MUTLU
1) Define plasma concentration-response relation.
2) Comment on starting period of the effect for drugs, peak effect time and chancing of period of the effect according to personal features.
3) Define pharmacokinetic principals
4) Explain drugs that requires monitoring of blood levels.
5) Explain the importance of monitoring blood levels of drugs.
Program Competencies | |||||||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
Learning Outcomes | |||||||||||||
1 | No relation | No relation | No relation | No relation | High | High | No relation | High | High | High | High | High | |
2 | No relation | No relation | No relation | No relation | High | High | No relation | High | High | High | High | High | |
3 | No relation | No relation | No relation | No relation | Middle | Middle | No relation | Middle | Middle | Middle | Middle | Middle | |
4 | No relation | No relation | No relation | No relation | Middle | Middle | No relation | Middle | Middle | Middle | Middle | Middle | |
5 | No relation | No relation | No relation | No relation | High | High | No relation | High | High | High | High | High |
Face to Face
None
Pharmacokinetics
There is an experimentally determined relationship between plasma drug concentration and the pharmacological effect. Knowledge of the drug level influences management. There is narrow therapeutic window There are potential patient compliance problems. The drug dose cannot be optimised by clinical observation alone.
2- Kayaalp SO
1) Lecture
2) Question-Answer
3) Discussion
Contribution of Midterm Examination to Course Grade |
30% |
---|---|
Contribution of Final Examination to Course Grade |
70% |
Total |
100% |
Turkish
Not Required